Tetsuo Nishikawa Selected Research

Tetsuo Nishikawa Research Topics

Disease

36	Hyperaldosteronism (Conn Syndrome) 02/2024 - 03/2002
35	Adenoma (Adenomas) 04/2024 - 03/2002
21	Hypertension (High Blood Pressure) 01/2024 - 03/2004
12	Neoplasms (Cancer) 11/2022 - 01/2008
11	Hyperplasia 02/2024 - 03/2002
10	Cushing Syndrome 11/2022 - 01/2008
8	Type 2 Diabetes Mellitus (MODY) 02/2022 - 07/2010
5	Diabetes Mellitus 02/2022 - 08/2005
5	Insulin Resistance 03/2019 - 04/2005
3	Pheochromocytoma 08/2022 - 01/2019
3	Inflammation (Inflammations) 02/2022 - 01/2017
3	Obesity 09/2021 - 01/2013
3	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2021 - 11/2020
3	Atherosclerosis 01/2020 - 12/2008
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2013 - 04/2005
2	Essential Hypertension 01/2024 - 11/2011
2	COVID-19 10/2022 - 01/2022
2	Infections 01/2022 - 01/2008
2	Dyslipidemias (Dyslipidemia) 11/2020 - 07/2020
2	Chronic Renal Insufficiency 01/2020 - 07/2013
2	Hyperglycemia 10/2019 - 01/2018
2	Glucose Intolerance 03/2019 - 04/2005
2	Renovascular Hypertension (Goldblatt Syndrome) 09/2018 - 03/2004
2	Hypokalemia 01/2014 - 01/2011
2	Hyperuricemia 01/2013 - 01/2010
2	Osteolysis 03/2004 - 08/2002
1	Asymptomatic Infections 10/2022
1	Neoplasm Metastasis (Metastasis) 08/2022
1	Periodontal Diseases (Periodontal Disease) 02/2022
1	Tooth Loss 02/2022
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2022
1	Carney Complex 01/2022
1	Cerebral Hemorrhage 01/2022
1	Rupture 12/2021
1	Paraganglioma (Paragangliomas) 05/2021
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 02/2021
1	Hyperlipoproteinemias 01/2021
1	Disease Progression 11/2020
1	Xanthomatosis (Xanthoma) 11/2020

Drug/Important Bio-Agent (IBA)

48	AldosteroneIBA 04/2024 - 03/2002
10	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2022 - 01/2012
10	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2022 - 03/2004
9	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 11/2022 - 01/2016
6	ReninIBA 01/2023 - 01/2011
6	Glucose (Dextrose)FDA LinkGeneric 10/2019 - 04/2005
5	Antihypertensive Agents (Antihypertensives)IBA 01/2024 - 11/2013
5	LipidsIBA 01/2021 - 04/2005
5	Insulin (Novolin)FDA Link 10/2019 - 04/2005
4	SteroidsIBA 02/2024 - 01/2010
4	Dexamethasone (Maxidex)FDA LinkGeneric 11/2022 - 03/2017
4	oxidized low density lipoproteinIBA 11/2020 - 12/2008
3	Angiotensin Receptor AntagonistsIBA 01/2024 - 01/2022
3	PotassiumIBA 01/2024 - 01/2022
3	CatecholaminesIBA 08/2022 - 01/2019
3	Hormones (Hormone)IBA 01/2022 - 01/2010
3	Blood Glucose (Blood Sugar)IBA 09/2021 - 07/2010
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 02/2021 - 01/2017
3	LDL CholesterolIBA 01/2021 - 01/2020
2	EnzymesIBA 02/2024 - 01/2013
2	18-oxocortisolIBA 02/2024 - 12/2018
2	Mineralocorticoid Receptor AntagonistsIBA 01/2023 - 01/2011
2	Immunoglobulin G (IgG)IBA 10/2022 - 01/2022
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2022 - 01/2022
2	DiureticsIBA 02/2021 - 11/2013
2	LDL Lipoproteins (beta Lipoproteins)IBA 11/2020 - 01/2020
2	Hemoglobins (Hemoglobin)IBA 07/2020 - 01/2011
2	HDL CholesterolIBA 01/2020 - 11/2018
2	Sitagliptin Phosphate (Januvia)FDA Link 11/2018 - 01/2017
2	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA 11/2017 - 01/2017
2	C-Reactive ProteinIBA 01/2017 - 07/2010
2	Uric Acid (Urate)IBA 01/2013 - 01/2010
2	Xanthine OxidaseIBA 01/2013 - 01/2010
2	Allopurinol (Remid)FDA LinkGeneric 01/2013 - 01/2010
2	Citric Acid (Citrate)FDA LinkGeneric 01/2013 - 01/2010
2	Proteins (Proteins, Gene)FDA Link 01/2008 - 09/2003
1	SaltsIBA 01/2024
1	SodiumIBA 01/2024
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2024
1	esaxerenoneIBA 01/2024
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2023
1	AntibodiesIBA 08/2022
1	3-Iodobenzylguanidine (Iobenguane)IBA 08/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	Platelet-Derived Growth FactorIBA 12/2021
1	CholesterolIBA 09/2021
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 05/2021
1	A-factor (Streptomyces)IBA 02/2021
1	ApolipoproteinsIBA 01/2021
1	LDL Receptors (LDL Receptor)IBA 11/2020
1	Proprotein Convertase 9IBA 11/2020

Therapy/Procedure

23	Adrenalectomy 01/2023 - 03/2002
4	Therapeutics 01/2023 - 02/2003
3	Glycemic Control 02/2022 - 01/2017
2	Arthroplasty 03/2004 - 08/2002
1	Punctures 01/2022
1	Radiofrequency Ablation 01/2022
1	Electrodes (Electrode) 01/2022
1	Bathroom Equipment 02/2021
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2020
1	Percutaneous Coronary Intervention 11/2020